Search Results - "Kulikowska de Nalecz, Anna"
-
1
The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of Age
Published in Cancers (02-07-2023)“…Fragility scales are intended to help in therapeutic decisions. Here, we asked if the fragility assessment in MM patients ≥ 75 years old qualified for…”
Get full text
Journal Article -
2
Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients
Published in International journal of molecular sciences (01-09-2021)“…Unlike solid-tumor patients, a disappointingly small subset of multiple myeloma (MM) patients treated with checkpoint inhibitors derive clinical benefits,…”
Get full text
Journal Article -
3
Inappropriate Expression of PD-1 and CTLA-4 Checkpoints in Myeloma Patients Is More Pronounced at Diagnosis: Implications for Time to Progression and Response to Therapeutic Checkpoint Inhibitors
Published in International journal of molecular sciences (01-03-2023)“…Multiple myeloma (MM) is a hematologic malignancy characterized by severely profound immune dysfunction. Therefore, the efficacy of drugs targeting the immune…”
Get full text
Journal Article -
4
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs
Published in Blood advances (13-09-2022)“…Myeloproliferative neoplasms (MPNs) are uncommon in children/young adults. Here, we present data on unselected patients diagnosed before 25 years of age…”
Get full text
Journal Article -
5
Breakthrough infections in MPN-COVID vaccinated patients
Published in Blood cancer journal (New York) (15-11-2022)Get full text
Journal Article -
6
Validation of thrombotic risk factors in 1381 patients with essential thrombocythaemia: A multicentre retrospective real‐life study
Published in British journal of haematology (01-10-2022)“…Summary Thrombosis and haemorrhage are frequent in patients with essential thrombocythaemia (ET). The 2016 revised International Prognostic Score for…”
Get full text
Journal Article -
7
Prediction of major bleeding events in 1381 patients with essential thrombocythemia
Published in International journal of hematology (01-11-2023)“…The goal of therapy in essential thrombocythemia (ET) is reducing thrombotic risk. No algorithm to predict hemorrhage risk exists. The impact ofanti-platelet,…”
Get full text
Journal Article -
8
Higher Prevalence of Chronic Kidney Disease in Myelodysplastic Syndromes Patients Compared to Age- Adjusted General Population - Results from the Polish Adult Leukemia Group (PALG) Registry
Published in Blood (02-11-2023)“…Introduction Chronic comorbidities that are common in the elderly population can have a significant impact on the clinical course, the choice of treatment, and…”
Get full text
Journal Article -
9
Impact of Cytoreductive Drugs upon Outcomes in a Contemporary Cohort of Adolescent and Young Adults with Essential Thrombocythemia and Polycythemia Vera
Published in Blood (02-11-2023)“…Introduction Essential thrombocythemia (ET) and polycythemia vera (PV) are well described in adolescent and young adults (AYA) patients (pts); the most…”
Get full text
Journal Article -
10
Primary cutaneous indolent B-cell lymphomas - a retrospective multicenter analysis and a review of literature
Published in Acta oncologica (03-10-2021)“…Primary cutaneous indolent B-cell lymphomas (PCBCLs) are not well characterized due to their rarity and indolent character. We retrospectively reviewed the…”
Get more information
Journal Article -
11
Second versus first wave of COVID-19 in patients with MPN
Published in Leukemia (01-03-2022)Get full text
Journal Article -
12
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID‐19
Published in American journal of hematology (01-12-2022)Get full text
Journal Article